Tandem Diabetes Care Q1 2025 10-Q Filing
Ticker: TNDM · Form: 10-Q · Filed: 2025-04-30T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, quarterly-report, medical-devices
Related Tickers: PODD
TL;DR
**TNDM Q1 2025 10-Q FILED. FINANCIALS OUT.**
AI Summary
Tandem Diabetes Care, Inc. filed its quarterly report for the period ending March 31, 2025. The company, headquartered in San Diego, CA, is involved in the surgical and medical instruments and apparatus industry. Key financial data and operational details for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors and analysts with the latest financial performance and operational updates for Tandem Diabetes Care, Inc. as of March 31, 2025.
Risk Assessment
Risk Level: medium — As a medical device company, Tandem Diabetes Care faces risks related to product development, regulatory approvals, market competition, and reimbursement policies.
Key Numbers
- N/A — Revenue (Specific revenue figures for Q1 2025 are not detailed in this header information.)
- N/A — Net Income (Specific net income figures for Q1 2025 are not detailed in this header information.)
- N/A — Earnings Per Share (Specific EPS figures for Q1 2025 are not detailed in this header information.)
Key Players & Entities
- TANDEM DIABETES CARE INC (company) — Filer
- San Diego, CA (location) — Business Address
- 20250331 (date) — Reporting Period End Date
- 20250430 (date) — Filing Date
FAQ
What were Tandem Diabetes Care's total revenues for the first quarter of 2025?
The provided header information does not contain specific revenue figures for the first quarter of 2025. The full 10-Q document would be needed for this detail.
Did Tandem Diabetes Care report a net profit or loss in the first quarter of 2025?
The header information does not specify the net income or loss for the first quarter of 2025. This detail would be found within the financial statements of the full 10-Q filing.
What is the company's primary business segment as indicated in the filing?
The company is classified under 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]'.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted on April 30, 2025.
What is the fiscal year-end for Tandem Diabetes Care?
The company's fiscal year ends on December 31.
From the Filing
0001438133-25-000069.txt : 20250430 0001438133-25-000069.hdr.sgml : 20250430 20250430161129 ACCESSION NUMBER: 0001438133-25-000069 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 82 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250430 DATE AS OF CHANGE: 20250430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 25895295 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 10-Q 1 tndm-20250331.htm 10-Q tndm-20250331 false 2025 Q1 0001438133 12/31 0.0289361 0.0088836 xbrli:shares iso4217:USD iso4217:USD xbrli:shares utr:sqft tndm:extension xbrli:pure tndm:trading_day tndm:segment tndm:market iso4217:CHF 0001438133 2025-01-01 2025-03-31 0001438133 2025-04-25 0001438133 2025-03-31 0001438133 2024-12-31 0001438133 2024-01-01 2024-03-31 0001438133 us-gaap:CommonStockMember 2024-12-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001438133 us-gaap:RetainedEarningsMember 2024-12-31 0001438133 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001438133 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001438133 us-gaap:CommonStockMember 2025-03-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001438133 us-gaap:RetainedEarningsMember 2025-03-31 0001438133 us-gaap:CommonStockMember 2023-12-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001438133 us-gaap:RetainedEarningsMember 2023-12-31 0001438133 2023-12-31 0001438133 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001438133 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001438133 us-gaap:CommonStockMember 2024-03-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001438133 us-gaap:RetainedEarningsMember 2024-03-31 0001438133 2024-03-31 0001438133 tndm:InsulinPumpMember srt:MinimumMember 2025-01-01 2025-03-31 0001438133 tndm:InsulinPumpMember 2025-01-01 2025-03-31 0001438133 tndm:InsulinPumpMember 2024-03-31 0001438133 tndm:SlimCartridgesAndInfusionSetsMember 2025-01-01 2025-03-31 0001438133 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001438133 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0001438133 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-03-31 0001438133 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0001438133 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001438133 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001438133 us-gaap:EmployeeStockMember 2025-01-01 2025-03-31 0001438133 us-gaap:EmployeeStockMember 2024-01-01 2024-03-31 0001438133 us-gaap:ConvertibleDebtSecuritiesMember 2025-01-01 2025-03-31 0001438133 us-gaap:ConvertibleDebtSecuritiesMember 2024-01-01 2024-03-31 0001438133 us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember 2025-03-31 0001438133 us-gaap:USTreasurySecuritiesMember 2025-03-31 0001438133 us-gaap:CommercialPaperMember 2025-03-31 0001438133 us-gaap:CorporateDebtSecuritiesMember 2025-03-31 0001438133 us-gaap:ForeignGovernmentDebtSecuritiesMember 202